BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3469151)

  • 1. The activity of ofloxacin against methicillin-resistant Staphylococcus aureus.
    Mraović M; Canić-Radojlović M
    Infection; 1986; 14 Suppl 4():S231-2. PubMed ID: 3469151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
    Smith SM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the in vitro activity of ofloxacin and gentamicin against isolates from hospitalised patients.
    Adeyemi-Doro FA; Rotowa NA
    Infection; 1986; 14 Suppl 4():S240-2. PubMed ID: 3469154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A; Lim VK; Rohani MY; Kamel AG
    Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological indications for the treatment of Staphylococcus aureus infections.
    Fabbri A; Tacchella A; Belli ML; Losurdo G
    Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus resistance to antibiotics and spread of phage types.
    Kareiviene V; Pavilonis A; Sinkute G; Liegiūte S; Gailiene G
    Medicina (Kaunas); 2006; 42(4):332-9. PubMed ID: 16687905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of susceptibility to antibiotics of Staphylococcus aureus strains resistant to methicillin].
    Trzciński K; Grzesiowski P; Marusak T; Zareba T; Tyski S; Hryniewicz W
    Med Dosw Mikrobiol; 1992; 44(3-4):93-6. PubMed ID: 1305928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of MICs on 16 antimicrobial agents for freshly isolated methicillin-resistant Staphylococcus aureus strains].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1990 Apr; 43(4):623-35. PubMed ID: 2381034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
    Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
    Peterson LR; Cooper I; Willard KE; Fasching CE; Sinn LM; Shanholtzer CJ; Gerding DN
    Chemotherapy; 1994; 40(1):21-5. PubMed ID: 8306811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
    Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
    Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981.
    Markowitz N; Pohlod DJ; Saravolatz LD; Quinn EL
    Antimicrob Agents Chemother; 1983 Mar; 23(3):450-7. PubMed ID: 6552151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short communication: Determination of methicillin resistance in staphylococci with different methods and detection of multiple antibiotic resistance].
    Cetinkol Y; Altindiş M; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2008 Jan; 42(1):119-24. PubMed ID: 18444569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
    Meyers BR; Srulevitch ES; Hirschman SZ
    Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
    Debbia E; Mannelli S; Gianrossi G; Schito GC
    Drugs Exp Clin Res; 1987; 13(4):213-7. PubMed ID: 3304918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents.
    Jordan GW; Hoeprich PD
    Antimicrob Agents Chemother; 1977 Jan; 11(1):7-12. PubMed ID: 584152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents.
    Thomas MG; Lang SD
    J Antimicrob Chemother; 1986 Aug; 18(2):171-5. PubMed ID: 3639086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.